139 related articles for article (PubMed ID: 21346876)
1. Comparative microarray data analysis for the expression of genes in the pathway of glioma.
Katara P; Sharma N; Sharma S; Khatri I; Kaushik A; Kaushal L; Sharma V
Bioinformation; 2010 Jun; 5(1):31-4. PubMed ID: 21346876
[TBL] [Abstract][Full Text] [Related]
2. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma.
Mijiti M; Maimaiti A; Chen X; Tuersun M; Dilixiati M; Dilixiati Y; Zhu G; Wu H; Li Y; Turhon M; Abulaiti A; Maimaitiaili N; Yiming N; Kasimu M; Wang Y
Mol Med; 2023 May; 29(1):64. PubMed ID: 37183261
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling predicts response to temozolomide in malignant gliomas.
Yoshino A; Ogino A; Yachi K; Ohta T; Fukushima T; Watanabe T; Katayama Y; Okamoto Y; Naruse N; Sano E; Tsumoto K
Int J Oncol; 2010 Jun; 36(6):1367-77. PubMed ID: 20428759
[TBL] [Abstract][Full Text] [Related]
5. Molecular classification of human gliomas using matrix-based comparative genomic hybridization.
Roerig P; Nessling M; Radlwimmer B; Joos S; Wrobel G; Schwaenen C; Reifenberger G; Lichter P
Int J Cancer; 2005 Oct; 117(1):95-103. PubMed ID: 15880582
[TBL] [Abstract][Full Text] [Related]
6. A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomas.
Ponnampalam SN; Kamaluddin NR; Zakaria Z; Matheneswaran V; Ganesan D; Haspani MS; Ryten M; Hardy JA
Oncol Rep; 2017 Jan; 37(1):10-22. PubMed ID: 28004117
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes and glial tumors.
Watkins D; Rouleau GA
Rev Neurol (Paris); 1992; 148(6-7):402-7. PubMed ID: 1448659
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway.
Dasari VR; Kaur K; Velpula KK; Gujrati M; Fassett D; Klopfenstein JD; Dinh DH; Rao JS
PLoS One; 2010 Apr; 5(4):e10350. PubMed ID: 20436671
[TBL] [Abstract][Full Text] [Related]
9. Differential lncRNA expression profiles in recurrent gliomas compared with primary gliomas identified by microarray analysis.
Chen Y; Wu JJ; Lin XB; Bao Y; Chen ZH; Zhang CR; Cai Z; Zhou JY; Ding MH; Wu XJ; Sun W; Qian J; Zhang L; Jiang L; Hu GH
Int J Clin Exp Med; 2015; 8(4):5033-43. PubMed ID: 26131076
[TBL] [Abstract][Full Text] [Related]
10. The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway.
Chen CW; Yang CH; Lin YH; Hou YC; Cheng TJ; Chang ST; Huang YH; Chung ST; Chio CC; Shan YS; Cheng HC; Chang WT
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917452
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of the circadian clock network correlates with tumour progression in gliomas.
Petkovic M; Yalçin M; Heese O; Relógio A
BMC Med Genomics; 2023 Jul; 16(1):154. PubMed ID: 37400829
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the miR-126 gene associated with glioma progression.
Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of the aberrant microRNA expression pattern in gliomas of different grades.
Zhu XP; Mou KJ; Xu QF; Tang JH; Huang GH; Xu JP; Li GH; Ai SJ; Hugnot JP; Zhou Z; Lv SQ
Oncol Rep; 2015 Jul; 34(1):318-24. PubMed ID: 25954994
[TBL] [Abstract][Full Text] [Related]
15. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma.
Zhu J; Lin Q; Zheng H; Rao Y; Ji T
Front Oncol; 2022; 12():897042. PubMed ID: 36505882
[TBL] [Abstract][Full Text] [Related]
16. An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types.
Staub E; Groene J; Heinze M; Mennerich D; Roepcke S; Klaman I; Hinzmann B; Castanos-Velez E; Pilarsky C; Mann B; Brümmendorf T; Weber B; Buhr HJ; Rosenthal A
J Mol Med (Berl); 2009 Jun; 87(6):633-44. PubMed ID: 19399471
[TBL] [Abstract][Full Text] [Related]
17. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
18. Isolation of novel differentially expressed genes related to human glioma using cDNA microarray and characterizations of two novel full-length genes.
Qi ZY; Li Y; Ying K; Wu CQ; Tang R; Zhou ZX; Chen ZP; Hui GZ; Xie Y
J Neurooncol; 2002 Feb; 56(3):197-208. PubMed ID: 12061725
[TBL] [Abstract][Full Text] [Related]
19. PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth.
Magne N; Rousseau V; Duarte K; Poëa-Guyon S; Gleize V; Mutel A; Schmitt C; Castel H; Idbaih A; Huillard E; Sanson M; Barnier JV
Cell Oncol (Dordr); 2021 Dec; 44(6):1257-1271. PubMed ID: 34550532
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiles for insular low-grade gliomas with putamen involvement.
Zhou C; Wang Y; Liu X; Liang Y; Fan Z; Jiang T; Wang Y; Wang L
J Neurooncol; 2018 Jul; 138(3):659-666. PubMed ID: 29556911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]